Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $30.0000 (-14.29%) ($27.0000 - $32.5500) on Mon. Nov. 11, 2013. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 11.11% (three month average) | RSI | 47 | Latest Price | $30.0000(-14.29%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -3.9% a day on average for past five trading days. | Weekly Trend | CAPR declines -3.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) IWM(5%) PEJ(5%) EWP(4%) XAR(4%) XOP(4%) | Factors Impacting CAPR price | CAPR will decline at least -5.555% in a week (0% probabilities). IGOV(-2%) EMHY(-2%) REMX(-1%) GLD(-1%) EWY(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -5.555% (StdDev 11.11%) | Hourly BBV | 0 () | Intraday Trend | -7.8% | | | |
|
Resistance Level | $36.58 | 5 Day Moving Average | $34.8(-13.79%) | 10 Day Moving Average | $34.61(-13.32%) | 20 Day Moving Average | $36.58(-17.99%) | To recent high | -35.5% | To recent low | 33.3% | Market Cap | $591m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |